Home‎ > ‎

Publications

Contreras A, Sen S, Tatar AJ, Mahvi DA, Meyers JV, Srinand R, Suresh M, Cho CS. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in miceCancer Immunology, Immunotherapy, 65(5): 601-11, 2016 May. doi: 10.1007/s00262-016-1823-8. 
PMID:
 
27011014

Contreras A, Cho CS. Cancer immunology. In: Scientific American: Surgery, Hamilton, ON: Decker Publishing, 2016.

Mahvi DA, Meyers JV, Tatar AJ, Contreras A, Suresh M, Leverson GE, Sen S, Cho CS. Ctla-4 blockade plus 
adoptive T-cell transfer promotes optimal melanoma immunity in mice.  Journal of Immunotherapy38(2):54-61, 2015 Feb-Mar. doi: 10.1097/CJI.0000000000000064.  PMID: 25658614 

Cho H, Cho CS, Indig GL, Lavasanifar A, Vakili MR, Kwon GS. Polymeric micelles for apoptosis-targeting of cancer and intraoperative surgical guidance. PLoS One, 9(2):e89968, 2014 Feb. doi: 10.1371/journal.pone.0089968. PMID: 24587157

Cho CS. Choosing a good basic science or translational research mentor. In: Kibbe M (Ed.) Success in Academic Surgery: Basic Science, London: Springer-Verlag 2014.


Wentworth L, Meyers JV, Alam S, Russ AJ, Suresh M, Cho CS. Memory T cells are uniquely resistant to melanoma-induced suppression.  Cancer Immunology, Immunotherapy, 
62(1):149-59, 2013 Jan. doi: 10.1007/s00262-012-1326-1. PMID: 22865267

Russ AJ, Xu K, Wentworth L, Alam S, Meyers JV, Macklin MD, Rakhmilevich AL, Rajamanickam V, Suresh M, Cho CS. Melanoma-induced suppression of tumor antigen-specific T cell expansion is
comparable to suppression of global T cell expansion. Cellular Immunology271(1):104-9, 2013. doi: 10.1016/j.cellimm.2011.06.011. PMID: 21741629

Russ Aj, Wentworth L, Xu K, Rakhmilevich A, Seroogy CM, Sondel PM, Suresh M, Cho CS. Suppression of T-cell expansion by melanoma is exerted on resting cells.  Annals of Surgical Oncology18(13):3848-57, 2011 Dec. doi: 10.1245/s10434-011-1667-6. 
PMID:
 
21465311

Cho CS. Cancer Immunology. In: American College of Surgeons Surgery: Principles and Practice, New York, NY: WebMD, 2011.

Cho CS, Chang Z, Elkahwaji J, Scheunemaa TL, Manthei ER, Colburn M, Knechtle SJ, Hamawy MM. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. International Immunology, 15(11): 1369-78, 2003 Nov. 
PMID:
 
14565935


Other Publications from Dr. Cho, including clinical:

RSS Feed


Presentations

Cho, CS. “Inhibition of CTL Expansion in Mice Bearing B16 Melanoma,” University of Wisconsin ImmunoOncology Working Group, Madison, WI (12/2007)

         Cho CS, Singh A, Rakhmilevich A, Seroogy CM, Suresh M, Sondel PM. “Cancer Induces Immune Suppression that is Proportional to Extent of Tumor Burden.” Academic Surgical Congress, Huntington Beach, CA (02/2008)

Cho CS, Singh A, Rakhmilevich A, Seroogy CM, Suresh M, Sondel PM. “The Presence of Tumor Inhibits Effector T Cell Expansion in Response to de novo Antigen.” American Association for Cancer Research, San Diego, CA (04/2008)

Cho, CS. “T Cell Homeostasis and Cancer,” University of Wisconsin ImmunoOncology Working Group, Madison, WI (09/2008) 

Cho, CS. “Animal Models,” Association for Academic Surgery Fundamentals of Surgical Research Course, San Francisco, CA (10/2008)

Cho, CS. “T Cell Homeostasis and Cancer,” University of Wisconsin Department of Surgery Research Seminar, Madison, WI (02/2009)

           Xu K, Russ A, Wentworth L, Cho CS. “Tumor-Induced Immune Suppression Does Not Affect Tumor-Specific Antigens More Potently than Tumor-Unrelated Antigens.” Academic Surgical Congress, Sanibel Island, FL (02/2009)

Russ AJ, Xu K, Wentworth L, Cho CS. “Tumor Growth Kinetics Determine Cancer-Induced Immune Suppression.” Academic Surgical Congress, Sanibel Island, FL (02/2009)

Cho, CS. “T cell Homeostasis and Melanoma,” Foundation Award Research Update, Central Surgical Association, Saratoga, FL (03/2009)

Cho, CS. “Immunological Homeostasis and Cancer,” University of Wisconsin Department of Surgery First Annual Research Summit, Madison, WI (05/2009) 

Cho, CS. “Melanoma-Associated Immune Suppression,” University of Wisconsin Melanoma Disease Oriented Working Group, Madison, WI (09/2009)

Cho, CS. “Animal Models,” Association for Academic Surgery Fundamentals of Surgical Research Course, Chicago, IL (10/2009)

Cho, CS. “A Quantitative Animal Model of Tumor-Induced Immune Suppression,” American College of Surgeons Scholarships Committee, Chicago, IL (10/2009)

Russ AJ, Wentworth L, Cho CS. “The Influence of Cancer on the Kinetics of T Cell Responsiveness.” Academic Surgical Congress, San Antonio, TX (02/2010).

Meyers JV, Russ AJ, Wentworth L, Cho CS. “Tumor Inhibition by Tumor-Specific T cells is Not Affected by Cancer Burden: an Animal Model of Immunotherapy.” University of Wisconsin Undergraduate Research Symposium, Madison, WI, 2010, Wisconsin Surgical Society, Kohler, WI (11/2010)

Wentworth L, Alam S, Russ AJ, Meyers JV, Cho CS. “Memory T Cells are Optimal Mediators of Adoptive Cancer Immunotherapy.” University of Wisconsin Department of Surgery Research Summit, Verona, WI (01/2011)

Russ AJ, Alam S, Wentworth L, Meyers JV, Mahvi D, Cho CS. “Adoptive T Cell Immunotherapy Unmasks Concomitant Immunity: Novel Insight into the Influence of Tumor Burden on Cancer Immunotherapy.” Society of Surgical Oncology Annual Cancer Symposium, Orlando, FL (03/2011)

Cho, CS. “Melanoma-induced alterations in T cell homeostasis: implications for adoptive immunotherapy,” Surgical Biology Club II, San Francisco, CA (10/2011)

Cho, CS. “Rethinking Cancer Immunotherapy,” University of Wisconsin Department of Surgery Grand Rounds, Madison, WI (01/2012)

Cho, CS. “Melanoma-induced Alterations of T Cell Homeostasis: Implications for Adoptive Immunotherapy,” University of Wisconsin Cellular and Molecular Pathology graduate program seminar, Madison, WI (02/2012)

Meyers JV, Mahvi DA, Russ AJ, Alam S, Wentworth L, Cho CS. “Memory T Cells are Uniquely Resistant to Melanoma-Induced Suppression.” Academic Surgical Congress, Las Vegas, NV (02/2012)

Cho CS. Melanoma-Induced Alterations in T Cell Homeostasis: Implications for Adoptive Immunotherapy.” SUS New Member Poster Session, Academic Surgical Congress, Las Vegas, NV (02/2012)

Cho, CS. “Bench to Bedside: Moving from Animals to Humans,” Association for Academic Surgery Fundamentals of Surgical Research Course, Chicago, IL (10/2012)

Mahvi DA, Meyers JV, Durbin S, Russ AJ, Wentworth L, Cho CS. CTLA-4 Blockade Improves the Balance of CD8+ Effector and CD4+ Regulatory T Cells Following Adoptive Cell Transfer Melanoma Immunotherapy.” American Association for Cancer Research Special Conference on Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances, Miami, FL (12/2012)

Mahvi DA, Wentworth L, Meyers JV, Cho CS. “Combination of Adoptive Cell Transfer with CTLA-4 Blockade Maximizes Melanoma Immunotherapy.” Academic Surgical Congress, New Orleans, Louisiana (02/2013)

Meyers JV, Wentworth L, Mahvi DA, Cho CS. Neoadjuvant Memory T Cell Transfer: a Novel Paradigm for Cancer Immunotherapy.” Academic Surgical Congress, New Orleans, Louisiana (02/2013)

Cho, CS. “Preclinical Optimization of Melanoma Adoptive Cell Transfer Immunotherapy,” University of Wisconsin Melanoma Disease Oriented Working Group, Madison, WI (04/2013)

Cho, CS. “Moving from Animals to Humans,” Association for Academic Surgery Fundamentals of Surgical Research Course, Washington, DC (10/2013)

Cho, CS. “Adoptive Cell Transfer and Checkpoint Blockade as Combinatorial Cancer Immunotherapy,” Invited speaker, University of Wisconsin Department of Surgery Research Summit, Madison, WI (01/2014)

Tatar AJ, Sen S, Meyers JV, Srirand P, Contreras A, Mahvi DA, Cho CS. “Combination Effector and Memory T Cell Immunotherapy: a Novel Approach for Optimal Anti-Cancer Immunity.” University of Wisconsin Department of Surgery Research Summit, Madison, WI (01/2014)

Cho, CS. “Adoptive Cell Transfer and Checkpoint Blockade as Combinatorial Cancer Immunotherapy,” Invited speaker, William S. Middleton Memorial VA Hospital Research Day, Madison, WI (05/2014)

Cho, CS. “A New Combinatorial Approach to Cancer Immunotherapy,” James IV Visiting Professorship Lecture, Hammersmith Hospital, London, England (06/2014)

Cho, CS. “Improving Cancer Immunotherapy,” James IV Visiting Professorship Lecture, St. Mary’s Hospital, London, England (06/2014)

Cho, CS. “Pancreatic Cancer Research at UWCCC: Hope,” Invited speaker, University of Wisconsin Carbone Cancer Center Pancreas Cancer Informational and Awareness Night (10/2014)

Contreras A, Tatar A, Sen S, Meyers J, Srirand P, Mahvi D, Cho CS. “Effector and Memory CD8+ T Cells Interaction and Melanoma Therapy.” Autumn Immunology Conference, Chicago, IL (11/2014).

Cho, CS. “Revisiting Adoptive Cell Transfer Immunotherapy for Cancer,” University of Wisconsin Department of Pathology Grand Rounds (11/2014)

Cho, CS. “Combinatorial Approaches to Immunotherapy,” Society of Clinical Surgery, Madison, Wisconsin (11/2014)

Cho, CS. “Cancer Immunotherapy: What is it, and How Should Surgeons Relate?” James IV Visiting Professorship Lecture, University of Calgary, Calgary, Canada (12/2014)

Cho, CS. “Surgical Implications of Cancer Immunotherapy,” James IV Visiting Professorship Lecture, University of Toronto, Toronto, Canada (12/2014)

Cho, CS. “Cancer Immunology,” University of Wisconsin Immunology 528 Lecture (12/2014) 

Meyers JV, Sen S, Tatar AJ, Mahvi DA, Contreras A, Srinand P, Cho CS. “Memory T Cell Infiltration in Hepatic cColorectal Adenocarcinoma Metastases.” Academic Surgical Congress, Las Vegas, NV (02/2015)

Cho, CS. “Polymeric Micelles as a Theranostic Modality for Peritoneal Surface Malignancies,” St. George Hospital, University of New South Wales Department of Surgery, Kogorah, Australia (05/2015)

Cho, CS. “Immunotherapy and the New Surgical Oncology,” Western Australian Clinical Oncology Group, Perth, Australia (05/2015) 

Cho, CS. “New Perspectives on Melanoma Immunotherapy,” American College of Surgeons Lecture, Royal Australasian College of Surgeons Meeting, Perth, Australia (05/2015)

Cho, CS. “Cancer Immunotherapy, Reimagined,” Vanderbilt University School of Medicine, Nashville, TN (09/2015)

Cho, CS. “How to Stay Updated in Basic/Translational Research,” Association for Academic Surgery Fundamentals of Surgical Research Course, Chicago, IL (10/2015)

Cho, CS. “An Update of Pancreas Cancer Clinical Research at UW,” University of Wisconsin Carbone Cancer Center Pancreas Cancer Informational and Awareness Night (10/2015)

Cho, CS. “Surgical Immunotherapy,” presentation to French Academy of Surgeons, Madison, WI (10/2015)

Contreras A, Tatar A, Sen S, Meyers J, Srinand P, Mahvi D, Cho CS. “Interaction Between Effector and Memory CD8+ T Cells Enhances Melanoma Adoptive Immunotherapy.” Society for Immunotherapy of Cancer, National Harbor, MD (11/2015)

Contreras A, Tatar A, Sen S, Beems M, Srinand P, Cho CS. “Adoptive Cell Transfer Unmasks Concomitant Tumor Immunity.” Autumn Immunology Conference, Chicago, IL (11/2015)

Cho, CS. “Cancer Immunology,” University of Wisconsin Immunology 528 Lecture (12/2015)

Cho, CS. “Getting Past the Career Development Award: A Clinician-Scientist Perspective,” Veterans Health Administration Office of Research and Development Career Development Award Symposium, Washington, DC (07/2016)

Beems MV, Contreras A, Luther TK, Tatar A, Srinand P, Sen S, Cho CS. “Importance of Lymphodepletion Prior to Cancer Immunotherapy with Specific T Cell Subsets.” Academic Surgical Congress, Las Vegas, NV (02/2017)

Beems MV, Contreras A, Tatar A, Sen S, Srinand P, Cho CS. “Optimization of Isolation and Expansion of Memory CD8+ T-Cells for Use in Adoptive Cell Transfer.” Society of Surgical Oncology Annual Cancer Symposium, Seattle, WA (03/2017)